U.S. Metals and Mining Stock News

Bilibili (NasdaqGS:BILI) has quietly slid over the past month, even as its year to date performance and double digit revenue and net income growth paint a more balanced picture for long term investors. See our latest analysis for Bilibili. At around $24.39 per share, the recent 30 day share price return of minus 6.84 percent and 90 day share price return of minus 12.96 percent suggest fading near term momentum, even though the year to date share price return of 42.38 percent and one year...

Earlier this month, Oklo Inc. filed a very large US$1.50 billion at-the-market Class A common stock offering to fund its capital-intensive advanced nuclear build-out while still pre-revenue. At the same time, reports of Oracle delaying key AI data center projects to 2028 have raised fresh questions about the timing of demand for Oklo’s planned microreactors. We’ll now examine how the combination of Oracle’s delayed AI data centers and Oklo’s sizable equity program shapes its investment...

Cidara Therapeutics (CDTX) has quietly delivered striking long term gains, with the stock up sharply over the past year and even more over the past 3 years, despite ongoing losses. See our latest analysis for Cidara Therapeutics. Most of that excitement is baked into the recent move, with a roughly 239 percent 3 month share price return feeding into an 864 percent 1 year total shareholder return. This suggests momentum is still very much with the bulls. If Cidara’s surge has you thinking more...

ADT (ADT) shares have been drifting lately, and that sideways action is starting to look interesting when you line it up with the company’s improving fundamentals and still modest valuation profile. See our latest analysis for ADT. At around $8.14 per share, ADT’s solid year to date share price return contrasts with its softer three year total shareholder return. This suggests sentiment has improved recently as investors reassess its growth and risk profile. If ADT’s steady reset has your...

If you are wondering whether Costco Wholesale is still worth buying at these levels, or if the best days are already priced in, you are not the only one asking that question right now. After an impressive multi year run where the stock is up 95.8% over 3 years and 151.2% over 5 years, more recent returns have cooled, with the share price down 3.2% over 7 days, 6.8% over 30 days, 5.4% year to date and 11.9% over the last year. Those moves come as investors digest a steady stream of headlines...

Ares Management (ARES) just joined the S&P 500 and several related indices, a shift that typically forces fresh buying from index funds and puts the stock on more institutional radar screens. See our latest analysis for Ares Management. That index promotion has arrived alongside a powerful 30 day share price return of 18.6 percent. However, the year to date share price return is slightly negative, and the five year total shareholder return of just over 300 percent shows the longer term...

Sociedad Química y Minera de Chile (NYSE:SQM) is back in focus as strong lithium demand, fueled by electric vehicle growth, collides with the company’s expanding production capacity and improving Specialty Plant Nutrition trends, reshaping the stock’s risk reward profile. See our latest analysis for Sociedad Química y Minera de Chile. After a rocky stretch that left its three year total shareholder return still in negative territory, Sociedad Química y Minera de Chile’s 30 day share price...

Earlier in December, the U.S. Navy announced ShipOS, a partnership authorizing up to US$448 million to deploy Palantir’s Foundry and AI Platform across the Maritime Industrial Base, aiming to unify data, streamline shipbuilding workflows, and cut bottlenecks from major yards to more than 100 suppliers. The scale and mission‑critical nature of ShipOS positions Palantir’s software not just as an analytics tool, but as core operating infrastructure for U.S. naval production. We’ll now examine...

Wondering if CareTrust REIT is still a smart buy after its big run up, or if the easy money has already been made? In this article, we break down whether the current share price really matches the underlying value. The stock has cooled slightly in the last week, down 3.1%, but it is still up 1.2% over the past month, 37.0% year to date, and 32.9% over the last year, with gains of 119.2% over three years and 104.1% over five years. Those moves have come as investors focus on CareTrust's...

If you have ever wondered whether Yelp is quietly turning into a value play while everyone chases flashier tech names, this is the moment to take a closer look. The stock has bounced 2.4% over the last week and 8.2% over the last month, even though it is still down 21.6% year to date and 22.8% over the past year. This hints that sentiment and risk perceptions may be starting to pivot. Recent headlines have focused on Yelp's ongoing push into higher value advertising tools and enhanced...

Assessing recent moves in News stock News (NWSA) has drifted lower over the past 3 months, even though revenue and net income are still growing. This sets up an interesting disconnect between the stock price and fundamentals. See our latest analysis for News. Zooming out, the share price has slid from recent highs to around $25.89. That weaker short term share price return contrasts sharply with a still impressive multi year total shareholder return, suggesting momentum has cooled as...

Wondering if Flowserve is still good value after its big run, or if the easy money has already been made? Here is a breakdown of whether the current price really reflects the underlying business. The stock has climbed 22.8% year to date and 19.6% over the last year, while longer term holders have seen gains of 151.8% over three years and 115.8% over five, even with a recent 2.8% pullback over the past week and a 4.9% rise in the last month to around $70.42. Part of this move has been fueled...

Compass (COMP) slid about 4% after investors digested reports that Google is testing home listing results directly in search, which could pose a potential long term headwind for traffic, agent engagement, and platform economics. See our latest analysis for Compass. Even with today’s pullback on the Google news, Compass’s 30 day share price return of roughly 10% and powerful year to date share price return near 80% suggest positive momentum. A standout three year total shareholder return above...

Talen Energy (TLN) just reshuffled its C suite, promoting Terry Nutt to President and appointing Cole Muller as CFO, while tightening executive contracts and equity plans to reinforce long term strategy and retention. See our latest analysis for Talen Energy. The reshuffle lands after a powerful run, with a roughly 77 percent year to date share price return and an 83 percent one year total shareholder return, even as the 90 day share price return has cooled. This suggests momentum is...

Commvault Systems (CVLT) just expanded its security toolkit through a new integration with Delinea, tying Commvault Cloud directly into Delinea’s Secret Server to tighten credential controls and support stricter compliance for enterprise customers. See our latest analysis for Commvault Systems. Despite solid execution in cyber resilience and AI enabled recovery, Commvault’s 1 year total shareholder return of minus 27.33 percent and steep 90 day share price return of minus 36.15 percent show...

Eve Holding previously entered into a US$1.00 billion agreement with Beta Technologies to purchase electric motors that will power its future aircraft and support progress toward initial test flights targeted around late 2025 or early 2026. The collaboration highlights how Eve is locking in a core propulsion technology early, aiming to reduce technical risk as it moves from concept to operational aircraft. We’ll now examine how this long-term US$1.00 billion motor supply deal shapes Eve...

FMC (FMC) has had a rough stretch lately, with the stock sliding over the past year even as revenue has inched higher. That disconnect is what makes the current setup interesting. See our latest analysis for FMC. Recent trading has been choppy, with the latest 1 day share price return of negative 5.68 percent adding to a steep 90 day share price return of negative 64.57 percent, and multi year total shareholder returns pointing to momentum that is still fading rather than turning. If FMC’s...

Recently, Butterfly Network announced a co-development and licensing agreement with Midjourney for its semiconductor-based ultrasound technology and launched Compass AI, an enterprise software platform aimed at improving point-of-care ultrasound documentation and workflow. Alongside these moves, director Larry Robbins increased his direct ownership by purchasing 21,370 Class A shares, signaling internal confidence in the company’s AI-enabled ultrasound roadmap. Next, we’ll examine how the...

Walt Disney (DIS) just inked a three year content and equity deal with OpenAI’s Sora platform, letting fans generate short videos with Disney, Marvel, Pixar, and Star Wars characters while Disney leans deeper into AI powered storytelling. See our latest analysis for Walt Disney. The OpenAI deal lands as Disney’s share price hovers around $111.62, with a 7 day share price return of 4.30 percent but a roughly flat 1 year total shareholder return. This suggests sentiment is improving yet the...

Earlier this month, Allegiant Travel Company amended its revolving credit agreement to extend potential borrowings of up to US$150.0 million to December 2030, while also adding Deutsche Bank AG New York Branch as a US$50.0 million lender alongside Barclays' US$100.0 million commitment. Separately, Allegiant announced a new Allegiant Hotels platform powered by Rocket Travel by Agoda, allowing its over 20 million Allways Rewards members to earn or redeem points on worldwide hotel bookings and...

Early trading context and recent performance Caris Life Sciences (CAI) has been drifting after a choppy stretch, with the stock down about 6% over the past week but still up roughly 12% over the past month. See our latest analysis for Caris Life Sciences. Zooming out, Caris Life Sciences’ share price return is still slightly negative year to date despite that recent 30 day rebound. This suggests momentum is stabilizing rather than clearly accelerating as investors reassess both growth...

Yext (YEXT) has quietly outperformed many software peers this year, and that kind of steady climb usually means investors see something durable in the story, not just a passing sentiment shift. See our latest analysis for Yext. At a share price of $8.51, Yext’s steady year to date share price return of just over 30 percent and 1 year total shareholder return above 31 percent suggest momentum is still building as investors reassess its growth and profitability profile. If Yext’s climb has you...

Toll Brothers (TOL) has quietly outpaced the broader homebuilder group this month, with the stock up roughly 6% while the past 3 months have been more sideways for investors. See our latest analysis for Toll Brothers. That move fits into a steadier backdrop, with an 11.33% year to date share price return and a powerful 3 year total shareholder return of 185.17% suggesting underlying confidence rather than speculative froth. If Toll Brothers has you rethinking the housing cycle, it could be a...

Value Line (VALU) opened Q2 2026 with total revenue of about $8.6 million and EPS of roughly $0.60, as investors weighed these latest numbers against its steadily profitable track record. The company has seen quarterly revenue move in a fairly tight band around the mid single digit millions over the past six quarters, while EPS has generally held in the low to mid $0.60 range from Q1 2025 through Q2 2026. This signals consistent earnings power that sets the stage for a closer look at what is...